More Clinical Articles


The Future of Clinical Trials?

Danielle Barron, (Jan 4, 2017)

Transforming a trial from a clinical ‘experiment’ to a standard care option.

Making the Patient-Centric Trial a Reality

Danielle Barron, (Dec 14, 2016)

Learn what a panel of experts had to say on how we can create value for patients in trials, keep them engaged, and treat them like gold.

Made to Measure

Danielle Barron, (Dec 7, 2016)

Pharma needs to measure the patient-centricity of its clinical trials as accurately as any other variable, says Professor Michael Howley

Engagement with Impact

Deirdre Coleman, (Dec 5, 2016)

Medical Science Liasions need more than just scientific acumen to get the message across.

The End of Paper?

Danielle Barron, (Nov 30, 2016)

Paperless clinical trials have gained momentum but what barriers need to be cleared before we say goodbye to paper forever?

Architects of Value

Deirdre Coleman, (Nov 28, 2016)

Dr Ameet Nathwani, Chief Medical Officer at Sanofi, discusses the vital role Medical Affairs is playing in using data to demonstrate value

The Changing Face of Medical Affairs

Deirdre Coleman, (Nov 22, 2016)

MA is set to become a fully-fledged strategic partner. But what has driven this change & what can we expect in years to come?

Siteless: The Future of Clinical Trials?

Danielle Barron, (Nov 17, 2016)

Clinical trials are moving out of the clinic and into patients’ own homes.

"I've Got Bad News"...

Adam Hill, (Oct 27, 2016)

Chief Medical Officers need to think about their tone when explaining why a development drug may go no further.

Ingenuity in the Fight Against Cancer

Danielle Barron, (Oct 19, 2016)

A Silicon Valley innovator, Robert Goldman, has turned his entrepreneurial instincts towards cancer treatment.